Infection Prevention Market Growth Outlook Through 2024-2033

Overview and Scope
Infection prevention refers to measures and practices to minimize the risk and spread of infectious diseases. These practices include hygiene measures such as hand washing, vaccination, and protective equipment. They are crucial in healthcare settings, public spaces, and personal care to protect individual and public health.

Sizing and Forecast
The infection prevention market size has grown steadily in recent years. It will grow from $41.64 billion in 2023 to $43.40 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing awareness of healthcare-associated infections (HAIS), stringent regulatory guidelines, advancements in technology, globalization and international travel, and rising healthcare expenditure.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report

Segmentation & Regional Insights
The infection prevention market covered in this report is segmented –
1) By Product: Sterilization Equipment, Disinfectors, Consumables
2) By Infection Type: Microbial Infections, Healthcare Associated Infections
3) By End User: Hospitals And Clinics, Pharmaceutical Companies, Clinical Laboratories, Medical Device Companies, Life Science Industry, Academic And Research Center

North America was the largest region in the infection prevention market in 2023. The regions covered in the infection prevention market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13863&type=smp

Major Driver Impacting Market Growth
The increase in the incidence of hospital-acquired infections is expected to fuel the growth of the infection prevention market going forward. Hospital-acquired infections refer to infections that patients acquire while receiving healthcare treatment in a hospital or other healthcare facility. Infection prevention strategies address hospital-acquired infections (HAIs) by implementing a range of measures designed to minimize the risk of infections and enhance patient safety. For instance, in December 2023, according to the Australian Institute of Health and Welfare, an Australia-based government agency, during 2021–22, hospitals reported 1,546 Staphylococcus aureus bloodstream infection (SABSI) cases, equating to a rate of 0.73 cases per 10,000 patient days. Further, MSSA infections were slightly higher at 0.62 per 10,000 patient days, compared to 0.61 in 2020–21. Therefore, the increase in the incidence of hospital-acquired infections is driving the growth of the infection prevention market.

Key Industry Players
Major companies operating in the infection prevention market report are Cardinal Health Inc., 3M Company, Stryker Corporation, Reckitt Benckiser Group plc, Ecolab Inc., B. Braun Melsungen AG, The Clorox Company, Olympus Corporation, Fortive Corporation, Steris PLC, Genitge AB, Sotera Health Inc., Belimed AG, Coltene Group, Steelco S.p.A., Skytron LLC, Melag Medizintechnik GmbH & Co. KG, Metrex Research, Pal International, Cisa Production S.r.l. Unipersonale , Covalon Technologies Ltd., Biosafe Systems LLC, Terragene SA, Micro-Scientific LLC , Matachana SA

The infection prevention market report table of contents includes:
1. Executive Summary